<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Assertio Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Assertio Therapeutics, Inc.

    Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Company’s core areas of neurology, orphan and specialty medicines. Assertio currently markets three FDA-approved products and continues to identify, license and develop new products that offer enhanced options for patients that may be underserved by existing therapies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Arthur J. Higgins
    • FOUNDED
      1995
    • EMPLOYEES
      101-250
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Outlook Therapeutics, Inc.

    Outlook Therapeutics, Inc.

    Outlook Therapeutics is a late clinical-stage biopharmaceutical company focused on...

    Outlook Therapeutics is a late clinical-stage b...

    Filing Type:    PU
    CONMED Corporation

    CONMED Corporation

    CONMED is a medical technology company that provides surgical devices and equipmen...

    CONMED is a medical technology company that pro...

    Filing Type:    PU
    Osmotica Pharmaceuticals plc

    Osmotica Pharmaceuticals plc

    Osmotica Pharmaceuticals plc is a fully-integrated biopharmaceutical company focus...

    Osmotica Pharmaceuticals plc is a fully-integra...

    Filing Type:    PU
    Oncolytics Biotech Inc.

    Oncolytics Biotech Inc.

    Oncolytics is focused on obtaining regulatory approval for pelareorep for metastat...

    Oncolytics is focused on obtaining regulatory a...

    Filing Type:    PU
    Liquidia Technologies, Inc.

    Liquidia Technologies, Inc.

    Liquidia is a late-stage clinical biopharmaceutical company focused on the develop...

    Liquidia is a late-stage clinical biopharmaceut...

    Filing Type:    PU
    PTC Therapeutics, Inc.

    PTC Therapeutics, Inc.

    PTC is a science-led, global biopharmaceutical company focused on the discovery, d...

    PTC is a science-led, global biopharmaceutical ...

    Filing Type:    PU
    Axovant Gene Therapies Ltd.

    Axovant Gene Therapies Ltd.

    Axovant is accelerating the development of innovative gene therapy products that a...

    Axovant is accelerating the development of inno...

    Filing Type:    PU
    Anavex Life Sciences Corp.

    Anavex Life Sciences Corp.

    Anavex utilizes precision genetic medicine to treat severe and devastating neurolo...

    Anavex utilizes precision genetic medicine to t...

    Filing Type:    PU
    Adamas Pharmaceuticals, Inc.

    Adamas Pharmaceuticals, Inc.

    Adamas Pharmaceuticals, Inc. is using its deep understanding of time-dependent bio...

    Adamas Pharmaceuticals, Inc. is using its deep ...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.